In 2006, the Board of the European Association of Nuclear Medicine (EANM) launched EANM Research Ltd (EARL) as an initiative to promote multicentre nuclear medicine and research.

EARL´s main objective is to improve nuclear medicine and its practice and to advance scientific initiatives as well as clinical research projects.

In light of the current worldwide pandemic of COVID-19 outbreak EARL is applying flexible data submission deadlines for Q2. You will be receiving the usual email reminders for the data due and timelines. However, if you are unable to perform the QC tests due in Q2 for your scanner(s), or are unable to submit the acquired data, your scanner(s) accreditation status will be maintained until Q3. If you are able to perform the tests and submit the data, we will process it and provide you the confirmation as usual. 


The EARL team understands that at present the situation is difficult for many and wish to offer our empathy and support during this time. We will inform you about further changes or decisions taken. 

>> print article